Results 201 to 210 of about 916,052 (349)
Synthetic Biology and Biomaterials Strategies to Deceive the Tumor Microenvironment in CAR-T Immunotherapy. [PDF]
SmallMarsico G, Gc S, Siciliano V.
europepmc +1 more source
Tales of Emergence—Synthetic Biology as a Scientific Community in the Making
, 2009 Susan Molyneux‐Hodgson, Morgan Meyer
openalex +2 more sources
Patentability of synthetic biology inventions in Europe [PDF]
, 2010 Berthold Rutz
openalex +1 more source
Molecular Oncology, EarlyView.CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir +12 more
wiley +1 more source
Coacervate Vesicles as Adaptive Platforms for Synthetic Biology and Smart Materials. [PDF]
ChemistryVicentini F, Battistin F, Gobbo P.
europepmc +1 more source
The impact of synthetic biology on drug discovery
, 2009 Wilfried Weber, Martin Fussenegger
openalex +1 more source
Building momentum for systems and synthetic biology in India [PDF]
, 2010 Remya Krishnan +2 more
openalex +1 more source
Molecular Oncology, EarlyView.A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He +8 more
wiley +1 more source
Broad-Host-Range Synthetic Biology: Rethinking Microbial Chassis as a Design Variable. [PDF]
ACS Synth BiolChan DTC, Bjerg J, Bernstein HC.
europepmc +1 more source